Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-11-001649
Filing Date
2011-05-26
Accepted
2011-05-26 16:54:47
Documents
2
Period of Report
2011-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K FILING DOCUMENT document.htm 6-K 4375
2 PRESS RELEASE newsrelease.htm EX-99 8686
  Complete submission text file 0001171843-11-001649.txt   14050
Mailing Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS CORP (Filer) CIK: 0001447028 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 11874944
SIC: 2834 Pharmaceutical Preparations